Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease

Bibliographic Details
Title: Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease
Authors: Kunal Dhiman, Veer Bala Gupta, Victor L. Villemagne, Dhamidhu Eratne, Petra L. Graham, Christopher Fowler, Pierrick Bourgeat, Qiao‐Xin Li, Steven Collins, Ashley I. Bush, Christopher C. Rowe, Colin L. Masters, David Ames, Eugene Hone, Kaj Blennow, Henrik Zetterberg, Ralph N. Martins
Source: Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 12, Iss 1, Pp n/a-n/a (2020)
Publisher Information: Wiley, 2020.
Publication Year: 2020
Collection: LCC:Neurology. Diseases of the nervous system
LCC:Geriatrics
Subject Terms: amyloid, biomarker, dementia, diagnosis, ELISA, neurodegeneration, Neurology. Diseases of the nervous system, RC346-429, Geriatrics, RC952-954.6
More Details: Abstract Introduction This study assessed the utility of cerebrospinal fluid (CSF) neurofilament light (NfL) in Alzheimer's disease (AD) diagnosis, its association with amyloid and tau pathology, as well as its potential to predict brain atrophy, cognition, and amyloid accumulation. Methods CSF NfL concentration was measured in 221 participants from the Australian Imaging, Biomarkers & Lifestyle Flagship Study of Ageing (AIBL). Results CSF NfL levels as well as NfL/amyloid β (Aβ42) were significantly elevated in AD compared to healthy controls (HC; P < .001), and in mild cognitive impairment (MCI) compared to HC (P = .008 NfL; P < .001 NfL/Aβ42). CSF NfL and NfL/Aβ42 differentiated AD from HC with an area under the receiver operating characteristic (ROC) curve (AUC) of 0.84 and 0.90, respectively. CSF NfL and NfL/Aβ42 predicted cortical amyloid load, brain atrophy, and cognition. Discussion CSF NfL is a biomarker of neurodegeneration, correlating with cognitive impairment and brain neuropathology.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2352-8729
Relation: https://doaj.org/toc/2352-8729
DOI: 10.1002/dad2.12005
Access URL: https://doaj.org/article/365c6fec1fde4184b2c9e8e883ae53b3
Accession Number: edsdoj.365c6fec1fde4184b2c9e8e883ae53b3
Database: Directory of Open Access Journals
More Details
ISSN:23528729
DOI:10.1002/dad2.12005
Published in:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Language:English